| Mr Fortunato David Azoulay, MPT | |
|
17595 Harvard Ave Ste C, Irvine, CA 92614-8522 | |
| (949) 233-1980 | |
| Not Available |
| Full Name | Mr Fortunato David Azoulay |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 17595 Harvard Ave Ste C, Irvine, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053560276 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT 21389 (California) | Primary |
| Provider Name | Gateway Rehab & Wellness Center Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1184746927 PECOS PAC ID: 7517094980 Enrollment ID: O20100416000619 |
News Archive
Lumos Pharma, Inc., a clinical stage biopharmaceutical company focused on development and commercialization of therapeutics for rare and neglected diseases, today announced that it has acquired the license for LUM-201, an investigational orally administered small molecule that promotes secretion of growth hormone from the pituitary gland, from Ammonett Pharma LLC.
The U.S. Patent and Trade Office (USPTO) plans to announce patent award approval on August 11 to Dimera Incorporated for treatment of symptoms of Peripheral Arterial Disease (PAD), which is alternatively known as Peripheral Vascular Disease (PVD).
For the first time, researchers have identified two genetic variants that interact to alter the brain responses to high-calorie foods, a tie that could aid in the development of targeted treatments for obesity and overweight. Researchers at Imperial College London led by Tony Goldstone, MD, PhD, of Consultant Endocrinologist, found that two gene variants - FTO and DRD2 - influenced activity in the brain reward system when looking at pictures of high-calorie foods.
Goodwin Biotechnology, Inc., a full service contract biomanufacturing company, today announced that it has signed a new Biopharmaceutical Development and Manufacturing Agreement with a multinational biopharmaceutical client. According to the agreement, Goodwin will develop the process to manufacture a unique therapeutic monoclonal antibody conjugate for diagnostic imaging purposes.
› Verified 9 days ago
| Provider Name | One Choice Physical Therapy, Inc. |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1912416744 PECOS PAC ID: 2567720402 Enrollment ID: O20171221002642 |
News Archive
Lumos Pharma, Inc., a clinical stage biopharmaceutical company focused on development and commercialization of therapeutics for rare and neglected diseases, today announced that it has acquired the license for LUM-201, an investigational orally administered small molecule that promotes secretion of growth hormone from the pituitary gland, from Ammonett Pharma LLC.
The U.S. Patent and Trade Office (USPTO) plans to announce patent award approval on August 11 to Dimera Incorporated for treatment of symptoms of Peripheral Arterial Disease (PAD), which is alternatively known as Peripheral Vascular Disease (PVD).
For the first time, researchers have identified two genetic variants that interact to alter the brain responses to high-calorie foods, a tie that could aid in the development of targeted treatments for obesity and overweight. Researchers at Imperial College London led by Tony Goldstone, MD, PhD, of Consultant Endocrinologist, found that two gene variants - FTO and DRD2 - influenced activity in the brain reward system when looking at pictures of high-calorie foods.
Goodwin Biotechnology, Inc., a full service contract biomanufacturing company, today announced that it has signed a new Biopharmaceutical Development and Manufacturing Agreement with a multinational biopharmaceutical client. According to the agreement, Goodwin will develop the process to manufacture a unique therapeutic monoclonal antibody conjugate for diagnostic imaging purposes.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Fortunato David Azoulay, MPT 17595 Harvard Ave Ste C, Irvine, CA 92614-8522 Ph: (949) 233-1980 | Mr Fortunato David Azoulay, MPT 17595 Harvard Ave Ste C, Irvine, CA 92614-8522 Ph: (949) 233-1980 |
News Archive
Lumos Pharma, Inc., a clinical stage biopharmaceutical company focused on development and commercialization of therapeutics for rare and neglected diseases, today announced that it has acquired the license for LUM-201, an investigational orally administered small molecule that promotes secretion of growth hormone from the pituitary gland, from Ammonett Pharma LLC.
The U.S. Patent and Trade Office (USPTO) plans to announce patent award approval on August 11 to Dimera Incorporated for treatment of symptoms of Peripheral Arterial Disease (PAD), which is alternatively known as Peripheral Vascular Disease (PVD).
For the first time, researchers have identified two genetic variants that interact to alter the brain responses to high-calorie foods, a tie that could aid in the development of targeted treatments for obesity and overweight. Researchers at Imperial College London led by Tony Goldstone, MD, PhD, of Consultant Endocrinologist, found that two gene variants - FTO and DRD2 - influenced activity in the brain reward system when looking at pictures of high-calorie foods.
Goodwin Biotechnology, Inc., a full service contract biomanufacturing company, today announced that it has signed a new Biopharmaceutical Development and Manufacturing Agreement with a multinational biopharmaceutical client. According to the agreement, Goodwin will develop the process to manufacture a unique therapeutic monoclonal antibody conjugate for diagnostic imaging purposes.
› Verified 9 days ago
Kimberly M. Maclean, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 3500 Barranca Pkwy, Suite 220, Irvine, CA 92606 Phone: 949-265-2442 Fax: 949-265-2448 | |
Ms. Luz O Blake, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 15715 Rockfield Boulevard, Suite 100, Irvine, CA 92618 Phone: 949-206-9100 Fax: 949-206-1648 | |
Davis Y Koh, DPT, MBA, GCS, CSCS Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 9080 Irvine Center Dr, Irvine, CA 92618 Phone: 949-540-5641 | |
Par Plus, Inc. Physical Therapist Medicare: Medicare Enrolled Practice Location: 16257 Laguna Canyon Rd, Suite # 150, Irvine, CA 92618 Phone: 949-727-0700 Fax: 949-727-0707 | |
Denise Marie Lane, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4482 Barranca Pkwy Ste 195, Irvine, CA 92604 Phone: 949-679-3337 Fax: 949-679-3336 | |
Matthew Hoang, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 17332 Von Karman Ave Ste 120, Irvine, CA 92614 Phone: 949-861-8600 | |
Shelly A Gadea, Physical Therapist Medicare: Medicare Enrolled Practice Location: 24 Hammond, Unit C, Irvine, CA 92618 Phone: 949-770-6022 Fax: 949-770-7084 |